Company
Inosi Therapeutics
Small molecule inhibitors for reversal of fibrosis
- Status
- Operatingas of 2026-09-19
- Business model
- B2B
- Headquarters
- Melbourne, Australia
- inositherapeutics.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Inosi is developing therapies to address fibrosis, a condition associated with many chronic diseases where tissue damage leads to scarring and a loss of organ function.
Funding snapshot
- Latest round
- Grant2025-06-20
Funding rounds
- Grant
- 2025-06-20
- Seed
- 2021-10-21
Loading relationship preview